Register for free
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

181.89 +3.46 (+1.94%)
Official Closing Price Updated: 7:00 PM EDT, Oct 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting results tomorrow morning. Here’s what to look for. 
Via StockStory
Grail Shares Spiked Wednesday: What's Going On?
Grail shares are trading higher Wednesday after the company announced a new collaboration with Quest Diagnostics aimed at improving provider access to its Galleri multi-cancer early detection test. 
Via Benzinga
Labcorp (LH) Reports Earnings Tomorrow: What To Expect
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings tomorrow before the bell. Here’s what to look for. 
Via StockStory
Encompass Health (EHC) Q4 Earnings: What To Expect
Health care services provider Encompass Health (NYSE:EHC) will be announcing earnings results tomorrow after the bell. Here’s what investors should know. 
Via StockStory
Quest’s (NYSE:DGX) Q4: Beats On Revenue
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 14.6% year on year to $2.62 billion. Its non-GAAP profit... 
Via StockStory
What 6 Analyst Ratings Have To Say About Quest Diagnostics
 
Via Benzinga
Why Quest Diagnostics Stock Was Blasting Higher Today
Via The Motley Fool
Analyst Expectations For Quest Diagnostics's Future
 
Via Benzinga
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below. 
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Quest Diagnostics Stock Hits Over 2-Month High On Q4 Beat, Dividend Hike: Retail Cheer Grows
Quest completed eight acquisitions in 2024, including LifeLabs, expanded its advanced diagnostics portfolio, and extended its market reach with new clinical, consumer, and health plan customers. 
Via Stocktwits
Quest Diagnostics Delivers Q4 Earnings Beat: The Details
Quest Diagnostics reported fourth-quarter revenue of $2.62 billion, beating analyst estimates of $2.58 billion, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of $2.23... 
Via Benzinga
How Is The Market Feeling About Quest Diagnostics?
 
Via Benzinga
The Analyst Landscape: 8 Takes On Quest Diagnostics
 
Via Benzinga
(DGX) - Analyzing Quest Diagnostics's Short Interest
 
Via Benzinga
How Is The Market Feeling About Quest Diagnostics?
 
Via Benzinga
Quest Diagnostics EPS Tops Predictions
Quest Diagnostics saw robust growth in earnings and revenue, surpassing expectations for Q4 2024. 
Via The Motley Fool
IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Friday's session: top gainers and losers in the S&P500 index
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
 
Via Benzinga
Earnings Scheduled For January 30, 2025
 
Via Benzinga
This Boeing Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
 
Via Benzinga
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S. 
Via News Direct
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA Approval 
From Mainz BioMed NV
Via GlobeNewswire
Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
 
Via Benzinga
Guardant Health Stock Sees RS Rating Jump To 83
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. 
Via Investor's Business Daily
Navigating Earnings Season: Weather Any Storm
The consequences of hurricanes like Helene and Milton are—typically—quickly shrugged aside by markets as one-off events. That is mostly correct. But not entirely so. For some companies, the revenue and... 
Via Talk Markets
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS